ADA Scientific Sessions 2026 Abstract

The Relationship between Diabetic Retinopathy and Glucose-Lowering Therapy in Type 2 Diabetes: Results of an Observational Retrospective Study

By Pamela Senesi, Anna Ferrulli, Stela Vujosevic, Livio Luzi

Study in peoplePopulations

The paper

Pamela Senesi, Anna Ferrulli, Stela Vujosevic, Livio Luzi

Milan

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1444-P

doi.org/10.2337/db26-1444-p

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Frontiers in Aging Neuroscience4 Oct 2026
COVID-19 tied to higher dementia risk in older adults with diabetes